The importance of association between angiotensin converting enzyme ACE Gene I D polymorphism and diabetic peripheral neuropathy       
Yazarlar (4)
Ahmet İnanır
Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Nurşah Başol
Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Doç. Dr. Nevin KARAKUŞ Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Serbülent Yiğit
Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale
Dergi Adı Gene
Dergi ISSN 0378-1119 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q4
Makale Dili İngilizce
Basım Tarihi 11-2014
Cilt No 530
Sayı 2
Sayfalar 253 / 256
DOI Numarası 10.1016/j.gene.2013.07.051
Özet
Background: Diabetic peripheral neuropathy (DPN) is a microvascular complication of diabetes mellitus (DM) due to decreasing quality of life. In the present study, it is aimed to evaluate angiotensin-converting enzyme (ACE) Gene I/D polymorphism in Turkish population. Materials and methods: Two hundred and thirty-five DPN patients and two hundred and eighty-one controls were enrolled in this study. Genomic DNA was isolated and genotyped using polymerase chain reaction (PCR) analyses for the ACE gene I/D polymorphism. Results: Baseline characteristics of the DPN patients according to ACE genotypes were similar, except for history of hypertension. The frequency of II genotype was significantly higher in patients with positive history of hypertension than the patients with negative history of hypertension (p. = 0.013). DD genotype of I/D polymorphism was found to be a susceptibility factor for DPN in homozygous form (p. = 0.032). According to allele frequencies, D allele of I/D polymorphism was found to be a susceptibility factor for DPN (p. = 0.031). Conclusion: ACE gene I/D polymorphism may research in DM patients to determine genetic predisposition for DPN. It can be useful for taking early measures and avoiding DPN in a Turkish population. © 2013 Elsevier B.V.
Anahtar Kelimeler
Angiotensin-converting enzyme | Bp | Diabetic peripheral neuropathy | Gene Polymorphism